Avid Radiopharmaceuticals, Inc.,

Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.

Business Model:

Revenue: $22M

Employees: 51-200

Detailed Avid Radiopharmaceuticals, Inc., Information

Avid Radiopharmaceuticals, Inc., was acquired by Eli Lilly.
The acquisition happend on 2010-11-08.
Details of the transaction were not public

Acquirer

Geographic Data

Avid Radiopharmaceuticals, Inc., headquarters map

Address: 3711 Market St

City: Philadelphia

State: PA

Zip: 19104

Country: US

Financial Info

Stage:

series d

Raised Last:

$35M

Raised Total:

$70M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Avid develops molecular imaging agents to aid medical management of chronic human diseases. They are located in Philadelphia, PA. Their mission is to develop new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies.

Contact Phone:
+12152980700

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
8/2005 Series A 1 - BioAdvance
BioAdvance
1/2006 Series A $0 BioAdvance
Lilly Ventures
OUP (Osage University Partners)
Pfizer Venture Investments
RK Ventures Group
BioAdvance
Lilly Ventures
OUP (Osage University Partners)
Pfizer Venture Investments
RK Ventures Group
5/2007 Series C $0 Lilly Ventures
RK Ventures Group
AllianceBernstein
Safeguard Scientifics
BioAdvance
Pfizer Venture Investments
Lilly Ventures
RK Ventures Group
AllianceBernstein
Safeguard Scientifics
BioAdvance
Pfizer Venture Investments
5/2009 Series D $0 AllianceBernstein
Alta Partners
BioAdvance
Lilly Ventures
OUP (Osage University Partners)
Pfizer Venture Investments
RK Ventures Group
Safeguard Scientifics
AllianceBernstein
Alta Partners
BioAdvance
Lilly Ventures
OUP (Osage University Partners)
Pfizer Venture Investments
RK Ventures Group
Safeguard Scientifics
1/2005 Seed Round 1 $500k BioAdvance
BioAdvance
5/2009 Series D 8 $34.5M AllianceBernstein
Alta Partners
BioAdvance
Lilly Ventures
OUP (Osage University Partners)
Pfizer Venture Investments
RK Ventures Group
Safeguard Scientifics
AllianceBernstein
Alta Partners
BioAdvance
Lilly Ventures
OUP (Osage University Partners)
Pfizer Venture Investments
RK Ventures Group
Safeguard Scientifics
5/2007 Series C 6 $26M Lilly Ventures
RK Ventures Group
AllianceBernstein
Safeguard Scientifics
Lilly Ventures
RK Ventures Group
AllianceBernstein
Safeguard Scientifics
1/2006 Series A 5 $8.9M
8/2005 Series A 1 -
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research